JP2003529593A5 - - Google Patents

Download PDF

Info

Publication number
JP2003529593A5
JP2003529593A5 JP2001572483A JP2001572483A JP2003529593A5 JP 2003529593 A5 JP2003529593 A5 JP 2003529593A5 JP 2001572483 A JP2001572483 A JP 2001572483A JP 2001572483 A JP2001572483 A JP 2001572483A JP 2003529593 A5 JP2003529593 A5 JP 2003529593A5
Authority
JP
Japan
Prior art keywords
hydroxymutilin
ester
carbamic acid
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2001572483A
Other languages
English (en)
Japanese (ja)
Other versions
JP2003529593A (ja
Filing date
Publication date
Priority claimed from GBGB0008260.2A external-priority patent/GB0008260D0/en
Priority claimed from GB0027182A external-priority patent/GB0027182D0/en
Application filed filed Critical
Priority claimed from PCT/EP2001/003594 external-priority patent/WO2001074788A1/en
Publication of JP2003529593A publication Critical patent/JP2003529593A/ja
Publication of JP2003529593A5 publication Critical patent/JP2003529593A5/ja
Pending legal-status Critical Current

Links

JP2001572483A 2000-04-04 2001-03-29 抗菌剤として用いるための2−ヒドロキシムチリンカルバメート誘導体 Pending JP2003529593A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
GB0008260.2 2000-04-04
GBGB0008260.2A GB0008260D0 (en) 2000-04-04 2000-04-04 Novel compounds
GB0027182.5 2000-11-04
GB0027182A GB0027182D0 (en) 2000-11-04 2000-11-04 Novel comounds
PCT/EP2001/003594 WO2001074788A1 (en) 2000-04-04 2001-03-29 2-hydroxy-mutilin carbamate derivatives for antibacterial use

Publications (2)

Publication Number Publication Date
JP2003529593A JP2003529593A (ja) 2003-10-07
JP2003529593A5 true JP2003529593A5 (https=) 2008-05-15

Family

ID=26244040

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2001572483A Pending JP2003529593A (ja) 2000-04-04 2001-03-29 抗菌剤として用いるための2−ヒドロキシムチリンカルバメート誘導体

Country Status (21)

Country Link
US (1) US6972297B2 (https=)
EP (1) EP1268443B1 (https=)
JP (1) JP2003529593A (https=)
KR (1) KR100758441B1 (https=)
CN (1) CN1210267C (https=)
AR (1) AR030203A1 (https=)
AT (1) ATE437860T1 (https=)
AU (2) AU2001263827B2 (https=)
BR (1) BR0109809A (https=)
CA (1) CA2405132A1 (https=)
CO (1) CO5280223A1 (https=)
CZ (1) CZ20023290A3 (https=)
DE (1) DE60139382D1 (https=)
ES (1) ES2328109T3 (https=)
HU (1) HUP0300370A3 (https=)
IL (1) IL151887A0 (https=)
MX (1) MXPA02009816A (https=)
NO (1) NO324229B1 (https=)
NZ (1) NZ521536A (https=)
PL (1) PL358666A1 (https=)
WO (1) WO2001074788A1 (https=)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0024811D0 (en) * 2000-10-10 2000-11-22 Smithkline Beecham Plc Novel compounds
US7176310B1 (en) 2002-04-09 2007-02-13 Ucb Sa Pyrimidinecarboxamide derivatives and their use as anti-inflammatory agents
GB0209262D0 (en) * 2002-04-23 2002-06-05 Biochemie Gmbh Organic compounds
JP4611020B2 (ja) * 2002-07-24 2011-01-12 ナブリバ・セラピユーテイクス・アクチエンゲゼルシヤフト 抗菌剤としてのプレウロムチリン(pleuromutilin)誘導体
GB0218578D0 (en) * 2002-08-09 2002-09-18 Glaxo Group Ltd Novel method
GB0308114D0 (en) * 2003-04-08 2003-05-14 Glaxo Group Ltd Novel compounds
FR2856685B1 (fr) * 2003-06-25 2005-09-23 Merck Sante Sas Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent
WO2006063801A1 (en) * 2004-12-13 2006-06-22 Glaxo Group Limited Novel polymorph of (5-amino-6-methoxy-3-pyridincarbonyl)carbamic acid 2-(s)-hydroxymutilin 14-ester
WO2006070671A1 (ja) * 2004-12-27 2006-07-06 Kyorin Pharmaceutical Co., Ltd. 12位置換ムチリン誘導体
WO2006099196A1 (en) * 2005-03-10 2006-09-21 Smithkline Beecham Corporation Novel method
TW200738701A (en) 2005-07-26 2007-10-16 Du Pont Fungicidal carboxamides
KR100695541B1 (ko) * 2005-10-31 2007-03-16 한국단자공업 주식회사 연결터미널
WO2007079173A2 (en) * 2005-12-30 2007-07-12 Emergent Biosolutions Inc. Novel 2-heteroaryloxy-phenol derivatives as antibacterial agents
CA2688008A1 (en) 2007-05-24 2008-11-27 Kyorin Pharmaceutical Co., Ltd. Mutilin derivative having heterocyclic aromatic ring carboxylic acid structure in substituent at 14-position
EP2014640A1 (en) * 2007-07-13 2009-01-14 Nabriva Therapeutics AG Pleuromutilin derivatives
JP2010100582A (ja) * 2008-10-24 2010-05-06 Kyorin Pharmaceut Co Ltd 14位置換基に複素芳香環カルボン酸構造を有するムチリン誘導体
EP2184273A1 (de) 2008-11-05 2010-05-12 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
EP2253617A1 (de) 2009-05-20 2010-11-24 Bayer CropScience AG Halogen-substituierte Verbindungen als Pestizide
KR102656841B1 (ko) 2015-06-17 2024-04-12 나브리바 테라퓨틱스 게엠베하 레파뮬린의 주사가능한 약제학적 제형
EP3930808A4 (en) 2019-02-27 2022-12-14 Oticara, Inc. METHODS OF TREATMENT OF NASAL, SINONASAL AND NASOPHARYNGEAL TISSUE INFECTION AND/OR INFLAMMATION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2205072T3 (es) * 1996-01-03 2004-05-01 Smithkline Beecham Plc Derivados carbamoiloxi de mutilina y su uso como agentes antibacterianos.
HUP0001741A3 (en) 1996-08-02 2000-11-28 Smithkline Beecham Plc Azabicyclic carbamoyloxy mutilin derivatives for antibacterial use, process for preparing them, pharmaceuticals contg. them and their use
UY25225A1 (es) 1997-10-29 2000-12-29 Smithkline Beecham Plc Derivados de pleuromutilina utiles como agentes antimicrobianos
FR2771008B1 (fr) 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
GB9817029D0 (en) 1998-08-05 1998-09-30 Smithkline Beecham Plc Novel compounds

Similar Documents

Publication Publication Date Title
JP2003529593A5 (https=)
TWI902715B (zh) 作為parp7抑制劑的嗒酮
EP3409667B1 (en) Amide compounds for the treatment of hiv infections
US10906895B2 (en) Processes for the preparation of benzodiazepine derivatives
CN109790168B (zh) 取代的吡咯嗪化合物及其用途
EP2943481B1 (en) (hetero)arylacetamide derivatives as antiretroviral agents
JP6524081B2 (ja) ジヒドロピリミジン化合物及び医薬におけるその適用
TWI699359B (zh) 4h-吡咯[3,2-c]吡啶-4-酮衍生物
CN104428293B (zh) 调节TNFα的苯并咪唑类
KR102932904B1 (ko) 새로운 화합물 및 그 용도
CN115443276B (zh) 吡啶并嘧啶酮衍生物及其作为芳烃受体调节剂的应用
EA021463B1 (ru) Пуриновые производные и их применение в качестве модуляторов толл-подобного рецептора 7
TW202120496A (zh) 作為cd38抑制劑之雜雙環醯胺
SG10202111648YA (en) Chemical compounds
AU2014272776A1 (en) Pyrazolopyrrolidine derivatives and their use in the treatment of disease
GB0004887D0 (en) Chemical compounds
AU2013249041A1 (en) Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an HIV infection
EP2017278A1 (en) Dihydropyrazolopyrimidinone derivative
EP3412675A1 (en) Imidazopyrrolidinone derivatives and their use in the treatment of disease
CN109970749A (zh) Hcv ns5a的抗病毒化合物抑制剂
JP2006515373A5 (https=)
EP3752506B1 (en) Pyrimidine derivatives for prevention and treatment of bacterial infections
ES2992772T3 (en) Benzothiazol-6-yl acetic acid derivatives and their use for treating hiv infection
WO2019154329A1 (zh) 具有bet抑制活性的化合物及其制备方法和用途
CA2417629A1 (en) Derivatives of variolin b